- Home
- BRDG vs FDMT Comparison
BRDG vs FDMT Comparison
Compare BRDG & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRDG
- FDMT
- Stock Information
- Founded
- BRDG 2009
- FDMT 2013
- Country
- BRDG United States
- FDMT United States
- Employees
- BRDG N/A
- FDMT N/A
- Industry
- BRDG Investment Managers
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- BRDG Finance
- FDMT Health Care
- Exchange
- BRDG Nasdaq
- FDMT Nasdaq
- Market Cap
- BRDG 439.3M
- FDMT 420.7M
- IPO Year
- BRDG 2021
- FDMT 2020
- Fundamental
- Price
- BRDG $9.93
- FDMT $7.99
- Analyst Decision
- BRDG Buy
- FDMT Strong Buy
- Analyst Count
- BRDG 8
- FDMT 9
- Target Price
- BRDG $10.94
- FDMT $46.75
- AVG Volume (30 Days)
- BRDG 278.1K
- FDMT 769.3K
- Earning Date
- BRDG 11-06-2024
- FDMT 11-13-2024
- Dividend Yield
- BRDG 5.23%
- FDMT N/A
- EPS Growth
- BRDG N/A
- FDMT N/A
- EPS
- BRDG 0.09
- FDMT N/A
- Revenue
- BRDG $404,932,000.00
- FDMT $17,000.00
- Revenue This Year
- BRDG $35.04
- FDMT N/A
- Revenue Next Year
- BRDG $33.34
- FDMT $57.85
- P/E Ratio
- BRDG $114.84
- FDMT N/A
- Revenue Growth
- BRDG 63.66
- FDMT N/A
- 52 Week Low
- BRDG $6.18
- FDMT $7.32
- 52 Week High
- BRDG $11.69
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- BRDG 47.40
- FDMT 40.80
- Support Level
- BRDG $9.44
- FDMT $8.04
- Resistance Level
- BRDG $10.02
- FDMT $8.96
- Average True Range (ATR)
- BRDG 0.44
- FDMT 0.60
- MACD
- BRDG -0.09
- FDMT 0.16
- Stochastic Oscillator
- BRDG 21.78
- FDMT 36.02
About BRDG Bridge Investment Group Holdings Inc.
Bridge Investment Group Holdings Inc is a vertically integrated investment manager, diversified across specialized asset classes. The company combines its nationwide operating platform with dedicated teams of investment professionals focused on various specialized and synergistic investment platforms, including real estate, credit, renewable energy, and secondaries strategies. Its broad range of products and vertically integrated structure allow it to capture new market opportunities and serve investors with various investment objectives. The company operates Its business in a single segment, alternative investment management, diversified across specialized and synergistic investment platforms.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.